XML 90 R75.htm IDEA: XBRL DOCUMENT v3.20.2
Segment Information - Schedules of Segment Information (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Segment Reporting Information [Line Items]        
Net revenue $ 464,662 $ 404,642 $ 963,195 $ 850,762
Cost of goods sold 319,666 296,381 633,244 606,124
Cost of goods sold impairment charges 759 3,012 2,215 56,309
Gross profit 144,237 105,249 327,736 188,329
Selling, general and administrative 80,944 67,281 158,920 151,717
Research and development 45,572 48,016 81,951 101,874
In-process research and development impairment charges 0 0 960 22,787
Intellectual property legal development expenses 3,550 2,511 4,820 6,677
Acquisition, transaction-related and integration expenses 1,787 3,519 4,362 9,551
Charges (gains) related to legal matters, net 1,300 0 5,800 0
Other operating expenses 2,120   6,743  
Restructuring and other charges 333 2,835 2,381 8,996
Operating income (loss) 10,751 (18,913) 68,542 (113,273)
Generics        
Segment Reporting Information [Line Items]        
Net revenue 306,559 335,064 659,145 717,541
AvKARE        
Segment Reporting Information [Line Items]        
Net revenue 63,847   121,817  
Operating Segments | Generics        
Segment Reporting Information [Line Items]        
Net revenue 306,559 335,064 659,145 717,541
Cost of goods sold 218,909 263,423 437,774 542,301
Cost of goods sold impairment charges 759 3,012 2,215 56,309
Gross profit 86,891 68,629 219,156 118,931
Selling, general and administrative 12,802 14,379 29,425 38,527
Research and development 40,316 45,448 69,350 95,599
In-process research and development impairment charges     960 22,787
Intellectual property legal development expenses 3,550 2,511 4,815 5,632
Acquisition, transaction-related and integration expenses   987   3,584
Charges (gains) related to legal matters, net 3,050   5,550  
Other operating expenses 657   703  
Restructuring and other charges   418   2,499
Operating income (loss) 26,516 4,886 108,353 (49,697)
Operating Segments | Specialty        
Segment Reporting Information [Line Items]        
Net revenue 94,256 69,578 182,233 133,221
Cost of goods sold 50,229 32,958 98,047 63,823
Cost of goods sold impairment charges 0 0 0 0
Gross profit 44,027 36,620 84,186 69,398
Selling, general and administrative 16,870 16,150 37,812 37,477
Research and development 5,256 2,568 12,601 6,275
In-process research and development impairment charges     0 0
Intellectual property legal development expenses 0 0 5 1,045
Acquisition, transaction-related and integration expenses   1,366   3,250
Charges (gains) related to legal matters, net (1,750)   250  
Other operating expenses 82   82  
Restructuring and other charges   0   178
Operating income (loss) 23,569 16,536 33,436 21,173
Operating Segments | AvKARE        
Segment Reporting Information [Line Items]        
Net revenue 63,847   121,817  
Cost of goods sold 50,528   97,423  
Cost of goods sold impairment charges 0   0  
Gross profit 13,319   24,394  
Selling, general and administrative 15,647   26,435  
Research and development 0   0  
In-process research and development impairment charges     0  
Intellectual property legal development expenses 0   0  
Charges (gains) related to legal matters, net 0   0  
Other operating expenses 0   0  
Operating income (loss) (2,328)   (2,041)  
Corporate and Other        
Segment Reporting Information [Line Items]        
Net revenue 0 0 0 0
Cost of goods sold 0 0 0 0
Cost of goods sold impairment charges 0 0 0 0
Gross profit 0 0 0 0
Selling, general and administrative 35,625 36,752 65,248 75,713
Research and development 0 0 0 0
In-process research and development impairment charges     0 0
Intellectual property legal development expenses 0 0 0 0
Acquisition, transaction-related and integration expenses   1,166   2,717
Charges (gains) related to legal matters, net 0   0  
Other operating expenses 1,381   5,958  
Restructuring and other charges   2,417   6,319
Operating income (loss) $ (37,006) $ (40,335) $ (71,206) $ (84,749)